(Q43952260)

28 November 2017

title

Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI. (English)

1 reference

28 November 2017

0 references

1 reference

13

Tanner M

1 reference

28 November 2017

Schellenberg DM

1

1 reference

28 November 2017

Acosta CJ

2

1 reference

28 November 2017

Galindo CM

3

1 reference

28 November 2017

Kahigwa E

4

1 reference

28 November 2017

Urassa H

5

1 reference

28 November 2017

Masanja H

6

1 reference

28 November 2017

Aponte JJ

7

1 reference

28 November 2017

Schellenberg JR

8

1 reference

28 November 2017

Fraser-Hurt N

9

1 reference

28 November 2017

Lwilla F

10

1 reference

28 November 2017

Menendez C

11

1 reference

28 November 2017

Mshinda H

12

1 reference

28 November 2017

Alonso PL

14

1 reference

28 November 2017

publication date

1 May 1999

1 reference

Tropical Medicine and International Health

28 November 2017

published in

1 reference

28 November 2017

volume

4

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

377-382

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00424.X

10.1046/J.1365-3156.1999.00424.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference